Nitrous oxide and Norvir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nitrous oxide (nitrous oxide) and Norvir (ritonavir). Common drug interactions include lipodystrophy acquired among females and lipodystrophy acquired among males.

The phase IV clinical study analyzes what interactions people have when they take Nitrous oxide and Norvir. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.

What is Nitrous oxide?

Nitrous oxide has active ingredients of nitrous oxide. eHealthMe is studying from 1,780 Nitrous oxide users. Check the latest studies of Nitrous oxide.

What is Norvir?

Norvir has active ingredients of ritonavir. It is often used in hiv infection. eHealthMe is studying from 24,973 Norvir users. Check the latest studies of Norvir.



On Jul, 26, 2026

66 people who take Nitrous oxide and Norvir together, and have interactions are studied.

Nitrous oxide and Norvir drug interactions.

What are the common drug interactions of Nitrous Oxide and Norvir, by gender? *:

female:

  1. Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
  2. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  3. Premature labour
  4. Exomphalos (weakness of the baby's abdominal wall where the umbilical cord joins it)
  5. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  6. Premature baby
  7. Anal atresia (anus is either not present or it is in the wrong place)
  8. Blood iron decreased
  9. Erythema (redness of the skin)
  10. Genitalia external ambiguous (external genitals don't appear to be clearly either male or female)

male:

  1. Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
  2. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  3. Mean cell volume decreased (less of the average red blood cell volume)
  4. Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
  5. Abnormal behaviour
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Anal atresia (anus is either not present or it is in the wrong place)
  8. Blood iron decreased
  9. Caudal regression syndrome (disorder that impairs the development of the lower (caudal) half of the body)
  10. Compulsive shopping

What are the common drug interactions of Nitrous Oxide and Norvir, by age (0-1 to 60+)? *:

0-1:

  1. Exomphalos (weakness of the baby's abdominal wall where the umbilical cord joins it)
  2. Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
  3. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  4. Premature baby
  5. Anal atresia (anus is either not present or it is in the wrong place)
  6. Blood iron decreased
  7. Erythema (redness of the skin)
  8. Gastrointestinal malformation
  9. Genitalia external ambiguous (external genitals don't appear to be clearly either male or female)
  10. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)

2-9:

n/a

10-19:

  1. Anal atresia (anus is either not present or it is in the wrong place)
  2. Blood iron decreased
  3. Caudal regression syndrome (disorder that impairs the development of the lower (caudal) half of the body)
  4. Erythema (redness of the skin)
  5. Exomphalos (weakness of the baby's abdominal wall where the umbilical cord joins it)
  6. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  7. Gastrointestinal malformation
  8. Genitalia external ambiguous (external genitals don't appear to be clearly either male or female)
  9. Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
  10. Musculoskeletal deformity (functional disability of the body's muscles, joints, tendons, ligaments and nerves)

20-29:

  1. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  2. Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
  3. Premature labour
  4. Circulatory collapse
  5. Dizziness
  6. Gestational diabetes (diabetes in pregnancy)
  7. Haemoglobin decreased
  8. Loss of consciousness
  9. Lymphocyte count decreased
  10. Mean cell haemoglobin decreased (less than normal haemoglobin per red blood cell in a sample of blood)

30-39:

n/a

40-49:

  1. Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
  2. Premature labour
  3. Gestational diabetes (diabetes in pregnancy)
  4. Maternal exposure during pregnancy (use of substance during pregnancy)
  5. Live birth
  6. Ataxia (loss of full control of bodily movements)
  7. Dysarthria (speech disorder)
  8. Fatigue (feeling of tiredness)
  9. Gait disturbance
  10. Alanine aminotransferase increased

50-59:

n/a

60+:

  1. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  2. Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
  3. Premature labour
  4. Alanine aminotransferase increased
  5. Aspartate aminotransferase increased
  6. Gestational diabetes (diabetes in pregnancy)
  7. Decreased appetite
  8. Maternal exposure during pregnancy (use of substance during pregnancy)
  9. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Gestational Diabetes (diabetes in pregnancy): 61 people, 92.42%
  2. Anencephaly (absence of a major portion of the brain, skull, and scalp that occurs during embryonic development): 4 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Nitrous oxide and Norvir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nitrous oxide and Norvir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nitrous oxide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Norvir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitrous oxide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Norvir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nitrous oxide and ritonavir (the active ingredients of Nitrous oxide and Norvir, respectively), and Nitrous oxide and Norvir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: